12:00 AM
Mar 22, 1999
 |  BC Week In Review  |  Company News  |  Other News

Elan other research news

ELN's Elan Pharmaceuticals subsidiary (South San Francisco, Calif.) and colleagues published in the Proceedings of the National Academy of Sciences that mice expressing a mutant form of amyloid...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >